Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Technological advancement and availability of new tests
3.2.1.2 Growing application of genetic testing in oncology and genetic diseases
3.2.1.3 Increasing consumer preference for personalized medicine
3.2.1.4 Growing demand for direct-to-consumer genetic testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of genetic testing
3.2.2.2 Dearth of experienced professionals and advanced infrastructure in developing and developed economies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Products & Services, 2021 - 2032 ($ Mn)
5.1 Key trends
5.2 Kits & reagents
5.3 Software & services
Chapter 6 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)
6.1 Key trends
6.2 Predictive testing
6.3 Carrier testing
6.4 Prenatal and newborn testing
6.5 Diagnostic testing
6.6 Pharmacogenomic testing
6.7 Nutrigenomics
6.8 Other test types
Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
7.1 Key trends
7.2 Cancer treatment
7.3 Tissue typing for transplantation
7.4 Forensic identity testing
7.5 Ancestry testing
7.6 Paternity testing
7.7 Other applications
Chapter 8 Market Estimates and Forecast, By Techniques, 2021 - 2032 ($ Mn)
8.1 Key trends
8.2 Polymerase chain reaction
8.3 DNA sequencing
8.3.1 Sanger sequencing
8.3.2 Next generation sequencing
8.4 Cytogenetic testing
8.4.1 Chromosome analysis (karyotyping)
8.4.2 Fluorescence in situ hybridization (FISH)
8.5 Microarrays
8.6 Gene expression profiling
Chapter 9 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals & clinics
9.3 Diagnostic laboratories
9.4 Forensic laboratories
9.5 Other end-users
Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 23 and ME, Inc.
11.2 Abbott Laboratories
11.3 Ambry genetics
11.4 Ancestry DNA
11.5 bioMerieux SA
11.6 BGI Genomics
11.7 Illumina, Inc.
11.8 Invitae Corporation
11.9 Luminex Corporation
11.10 Myriad Genetics, Inc.
11.11 Natera, Inc.
11.12 QIAGEN N.V.
11.13 Quest Diagnostics
11.14 Siemens Healthineers AG
